{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:53:42Z","timestamp":1790798022992,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12015-025-11047-8","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:27:49Z","timestamp":1767493669000},"page":"1127-1138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunomodulatory Agents and Factors in Poor Hematopoietic Stem Cell Mobilization: Current Strategies and Future Prospects"],"prefix":"10.1007","volume":"22","author":[{"given":"Iraj","family":"Alipourfard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahere","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Saharkhiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Zelazewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"issue":"1","key":"11047_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbmt.2013.11.008","volume":"20","author":"O Fasan","year":"2014","unstructured":"Fasan, O. (2014). Optimal autologous peripheral blood progenitor cell mobilization involves more than the CD34\u2009+\u2009Yield. Biology of Blood and Marrow Transplantation, 20(1), 2\u20133.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"S12","key":"11047_CR2","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2728::AID-CNCR52>3.0.CO;2-A","volume":"80","author":"CM Richman","year":"1997","unstructured":"Richman, C. M., et al. (1997). Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma. Cancer: Interdisciplinary International Journal of the American Cancer Society, 80(S12), 2728\u20132732.","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"issue":"28","key":"11047_CR3","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"JF DiPersio","year":"2009","unstructured":"DiPersio, J. F., et al. (2009). Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin\u2019s lymphoma. Journal of Clinical Oncology, 27(28), 4767\u20134773.","journal-title":"Journal of Clinical Oncology"},{"issue":"9152","key":"11047_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(99)00268-8","volume":"353","author":"A Tabilio","year":"1999","unstructured":"Tabilio, A., et al. (1999). Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. The Lancet, 353(9152), 555.","journal-title":"The Lancet"},{"issue":"1","key":"11047_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/bmt.2010.78","volume":"46","author":"L Costa","year":"2011","unstructured":"Costa, L., et al. (2011). Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization. Bone Marrow Transplantation, 46(1), 64\u201369.","journal-title":"Bone Marrow Transplantation"},{"key":"11047_CR6","unstructured":"Watts, M. J. (1999). Human Haemopoietic progenitor cell mobilization. University of London, University College London (United Kingdom)."},{"issue":"1","key":"11047_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/10428194.2017.1324161","volume":"59","author":"G Milone","year":"2018","unstructured":"Milone, G., et al. (2018). Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma. Leukemia & Lymphoma, 59(1), 42\u201348.","journal-title":"Leukemia & Lymphoma"},{"issue":"15","key":"11047_CR8","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1182\/bloodadvances.2020002127","volume":"4","author":"KD Kokkaliaris","year":"2020","unstructured":"Kokkaliaris, K. D., & Scadden, D. T. (2020). Cell interactions in the bone marrow microenvironment affecting myeloid malignancies. Blood Advances, 4(15), 3795\u20133803.","journal-title":"Blood Advances"},{"issue":"6","key":"11047_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","volume":"25","author":"T Sugiyama","year":"2006","unstructured":"Sugiyama, T., et al. (2006). Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity, 25(6), 977\u2013988.","journal-title":"Immunity"},{"issue":"7","key":"11047_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/ni813","volume":"3","author":"I Petit","year":"2002","unstructured":"Petit, I., et al. (2002). G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and upregulating CXCR4. Nature Immunology, 3(7), 687\u2013694.","journal-title":"Nature Immunology"},{"key":"11047_CR11","doi-asserted-by":"publisher","first-page":"204062072311743","DOI":"10.1177\/20406207231174304","volume":"14","author":"ZD Crees","year":"2023","unstructured":"Crees, Z. D., Rettig, M. P., & DiPersio, J. F. (2023). Innovations in hematopoietic stem-cell mobilization: A review of the novel CXCR4 inhibitor motixafortide. Therapeutic Advances in Hematology, 14, 20406207231174304.","journal-title":"Therapeutic Advances in Hematology"},{"key":"11047_CR12","doi-asserted-by":"crossref","unstructured":"Laterveer, L. (1996). Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood, 15;87(2), 781\u2013788.","DOI":"10.1182\/blood.V87.2.781.bloodjournal872781"},{"issue":"6","key":"11047_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ncb3346","volume":"18","author":"EM Pietras","year":"2016","unstructured":"Pietras, E. M., et al. (2016). Chronic interleukin-1 exposure drives Haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nature Cell Biology, 18(6), 607\u2013618.","journal-title":"Nature Cell Biology"},{"issue":"7","key":"11047_CR14","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/leu.2012.17","volume":"26","author":"I Winkler","year":"2012","unstructured":"Winkler, I., et al. (2012). Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia, 26(7), 1594\u20131601.","journal-title":"Leukemia"},{"issue":"3","key":"11047_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000477262","volume":"44","author":"R Richter","year":"2017","unstructured":"Richter, R., Forssmann, W., & Henschler, R. (2017). Current developments in mobilization of hematopoietic stem and progenitor cells and their interaction with niches in bone marrow. Transfusion Medicine and Hemotherapy, 44(3), 151\u2013164.","journal-title":"Transfusion Medicine and Hemotherapy"},{"issue":"104","key":"11047_CR16","doi-asserted-by":"publisher","first-page":"104ra101","DOI":"10.1126\/scitranslmed.3002191","volume":"3","author":"F Ferraro","year":"2011","unstructured":"Ferraro, F., et al. (2011). Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Science Translational Medicine, 3(104), 104ra101\u2013104ra101.","journal-title":"Science Translational Medicine"},{"issue":"12","key":"11047_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nrendo.2014.169","volume":"10","author":"BJ Adler","year":"2014","unstructured":"Adler, B. J., Kaushansky, K., & Rubin, C. T. (2014). Obesity-driven disruption of haematopoiesis and the bone marrow niche. Nature Reviews Endocrinology, 10(12), 737\u2013748.","journal-title":"Nature Reviews Endocrinology"},{"issue":"6","key":"11047_CR18","doi-asserted-by":"publisher","first-page":"e0179986","DOI":"10.1371\/journal.pone.0179986","volume":"12","author":"S Shin","year":"2017","unstructured":"Shin, S., et al. (2017). A novel association between relaxin receptor polymorphism and hematopoietic stem cell yield after mobilization. PloS One, 12(6), e0179986.","journal-title":"PloS One"},{"issue":"1","key":"11047_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13287-021-02240-w","volume":"12","author":"M Zayed","year":"2021","unstructured":"Zayed, M., et al. (2021). Characterization of stable hypoxia-preconditioned dental pulp stem cells compared with mobilized dental pulp stem cells for application for pulp regenerative therapy. Stem Cell Research & Therapy, 12(1), 302.","journal-title":"Stem Cell Research & Therapy"},{"issue":"7","key":"11047_CR20","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.20122252","volume":"210","author":"S Pinho","year":"2013","unstructured":"Pinho, S., et al. (2013). PDGFR\u03b1 and CD51 mark human nestin\u2009+\u2009sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. Journal of Experimental Medicine, 210(7), 1351\u20131367.","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"11047_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1365-2141.2006.06218.x","volume":"134","author":"DN Haylock","year":"2006","unstructured":"Haylock, D. N., & Nilsson, S. K. (2006). Osteopontin: A Bridge between bone and blood. British Journal of Haematology, 134(5), 467\u2013474.","journal-title":"British Journal of Haematology"},{"issue":"9","key":"11047_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3727\/096368913X667709","volume":"23","author":"X Liang","year":"2014","unstructured":"Liang, X., et al. (2014). Paracrine mechanisms of mesenchymal stem cell-based therapy: Current status and perspectives. Cell Transplantation, 23(9), 1045\u20131059.","journal-title":"Cell Transplantation"},{"issue":"9","key":"11047_CR23","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1182\/blood-2004-01-0272","volume":"106","author":"CL Semerad","year":"2005","unstructured":"Semerad, C. L., et al. (2005). G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood, 106(9), 3020\u20133027.","journal-title":"Blood"},{"issue":"1","key":"11047_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4049\/jimmunol.182.1.604","volume":"182","author":"JM Petty","year":"2009","unstructured":"Petty, J. M., et al. (2009). Crosstalk between CXCR4\/stromal derived factor-1 and VLA-4\/VCAM-1 pathways regulates neutrophil retention in the bone marrow. The Journal of Immunology, 182(1), 604\u2013612.","journal-title":"The Journal of Immunology"},{"issue":"8","key":"11047_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.20041385","volume":"201","author":"HE Broxmeyer","year":"2005","unstructured":"Broxmeyer, H. E., et al. (2005). Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. The Journal of Experimental Medicine, 201(8), 1307\u20131318.","journal-title":"The Journal of Experimental Medicine"},{"key":"11047_CR26","doi-asserted-by":"publisher","first-page":"806069","DOI":"10.3389\/fvets.2022.806069","volume":"9","author":"B Uberti","year":"2022","unstructured":"Uberti, B., Plaza, A., & Henr\u00edquez, C. (2022). Preconditioning strategies for mesenchymal stromal\/stem cells in inflammatory conditions of livestock species. Frontiers in Veterinary Science, 9, 806069.","journal-title":"Frontiers in Veterinary Science"},{"issue":"7","key":"11047_CR27","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1182\/blood-2008-10-184721","volume":"114","author":"P Ramirez","year":"2009","unstructured":"Ramirez, P., et al. (2009). BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood, 114(7), 1340\u20131343.","journal-title":"Blood"},{"issue":"2","key":"11047_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","volume":"124","author":"Y Katayama","year":"2006","unstructured":"Katayama, Y., et al. (2006). Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell, 124(2), 407\u2013421.","journal-title":"Cell"},{"issue":"7","key":"11047_CR29","first-page":"1331","volume":"114","author":"MJ Christopher","year":"2009","unstructured":"Christopher, M. J., et al. (2009). Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood the Journal of the American Society of Hematology, 114(7), 1331\u20131339.","journal-title":"Blood the Journal of the American Society of Hematology"},{"issue":"2","key":"11047_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","volume":"37","author":"AM Hanash","year":"2012","unstructured":"Hanash, A. M., et al. (2012). Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity, 37(2), 339\u2013350.","journal-title":"Immunity"},{"issue":"1","key":"11047_CR31","first-page":"44","volume":"139","author":"LV Kovtonyuk","year":"2022","unstructured":"Kovtonyuk, L. V., et al. (2022). IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood the Journal of the American Society of Hematology, 139(1), 44\u201358.","journal-title":"Blood the Journal of the American Society of Hematology"},{"issue":"6","key":"11047_CR32","doi-asserted-by":"publisher","first-page":"a041197","DOI":"10.1101\/cshperspect.a041197","volume":"14","author":"A Singh","year":"2024","unstructured":"Singh, A., et al. (2024). Aging and inflammation. Cold Spring Harbor Perspectives in Medicine, 14(6), a041197.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"11047_CR33","doi-asserted-by":"publisher","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang, B., Lang, X., & Li, X. (2022). The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Frontiers in Oncology, 12, 1023177.","journal-title":"Frontiers in Oncology"},{"key":"11047_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12020-015-0741-4","volume":"51","author":"Y He","year":"2016","unstructured":"He, Y., et al. (2016). The multimerization and secretion of adiponectin are regulated by TNF-alpha. Endocrine, 51, 456\u2013468.","journal-title":"Endocrine"},{"issue":"18","key":"11047_CR35","first-page":"2051","volume":"136","author":"HF Gleitz","year":"2020","unstructured":"Gleitz, H. F., et al. (2020). Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN. Blood. The Journal of the American Society of Hematology, 136(18), 2051\u20132064.","journal-title":"The Journal of the American Society of Hematology"},{"issue":"6382","key":"11047_CR36","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A., & Wolchok, J. D. (2018). Cancer immunotherapy using checkpoint Blockade. Science, 359(6382), 1350\u20131355.","journal-title":"Science"},{"key":"11047_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-017-4308-3","volume":"165","author":"C Fan","year":"2017","unstructured":"Fan, C., et al. (2017). Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model. Breast Cancer Research and Treatment, 165, 41\u201351.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"7252","key":"11047_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature08099","volume":"460","author":"O Naveiras","year":"2009","unstructured":"Naveiras, O., et al. (2009). Bone-marrow adipocytes as negative regulators of the Haematopoietic microenvironment. Nature, 460(7252), 259\u2013263.","journal-title":"Nature"},{"issue":"1","key":"11047_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13287-022-02802-6","volume":"13","author":"C Luo","year":"2022","unstructured":"Luo, C., et al. (2022). Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: A systematic review and network meta-analysis of randomized controlled trials. Stem Cell Research & Therapy, 13(1), 123.","journal-title":"Stem Cell Research & Therapy"},{"key":"11047_CR40","doi-asserted-by":"crossref","unstructured":"U\u00e7kan-\u00c7etinkaya, D., & Murato\u011flu, B. (2022). Response of the bone marrow stem cells and the microenvironment to stress: marrow adipose tissue and Leukemia, in handbook of stem cell therapy (pp. 1179\u20131228). Springer.","DOI":"10.1007\/978-981-19-2655-6_22"},{"issue":"7","key":"11047_CR41","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.bbmt.2012.01.005","volume":"18","author":"M Hamadani","year":"2012","unstructured":"Hamadani, M., et al. (2012). Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies. Biology of Blood and Marrow Transplantation, 18(7), 1128\u20131135.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"11","key":"11047_CR42","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1007\/s00520-021-06266-x","volume":"29","author":"C Cerchione","year":"2021","unstructured":"Cerchione, C., Nappi, D., & Martinelli, G. (2021). Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma. Supportive Care in Cancer, 29(11), 6973\u20136980.","journal-title":"Supportive Care in Cancer"},{"key":"11047_CR43","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00277-019-03800-0","volume":"99","author":"X Ding","year":"2020","unstructured":"Ding, X., et al. (2020). Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma. Annals of Hematology, 99, 1331\u20131339.","journal-title":"Annals of Hematology"},{"key":"11047_CR44","doi-asserted-by":"crossref","unstructured":"Douglas, K. (2011). Experience with apheresis procedures after plerixafor mobilisation. Novel developments in stem cell mobilization: Focus on CXCR4 (pp. 133\u2013163). Springer Nature. Boston, MA.","DOI":"10.1007\/978-1-4614-1960-0_8"},{"issue":"11","key":"11047_CR45","first-page":"4099","volume":"91","author":"JF Pruijt","year":"1998","unstructured":"Pruijt, J. F., et al. (1998). Anti\u2013LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood. The Journal of the American Society of Hematology, 91(11), 4099\u20134105.","journal-title":"The Journal of the American Society of Hematology"},{"key":"11047_CR46","unstructured":"Mickien\u0117, G. (2022). Generation, purification and characterization of homo-and heterodimers of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF). Vilniaus universitetas."},{"issue":"6","key":"11047_CR47","first-page":"1041","volume":"168","author":"C Ho","year":"2017","unstructured":"Ho, C., Chi, M. (2017). Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling Cell, 168(6): 1041\u20131052e18.","journal-title":"Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling Cell"},{"issue":"3","key":"11047_CR48","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1182\/blood-2006-06-031401","volume":"110","author":"S Fukuda","year":"2007","unstructured":"Fukuda, S., et al. (2007). The chemokine GRO\u03b2 mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood, 110(3), 860\u2013869.","journal-title":"Blood"},{"issue":"1\u20132","key":"11047_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cell.2017.11.003","volume":"172","author":"J Hoggatt","year":"2018","unstructured":"Hoggatt, J., et al. (2018). Rapid mobilization reveals a highly engraftable hematopoietic stem cell. Cell, 172(1\u20132), 191\u2013204e10.","journal-title":"Cell"},{"issue":"1","key":"11047_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.17925\/EOH.2007.0.0.47","volume":"1","author":"HE Broxmeyer","year":"2007","unstructured":"Broxmeyer, H. E., & Campbell, T. B. (2007). Modulating the interaction of Stromal-cell-derived Factor-1\/CXCL12 and its Receptor, CXCR4, for enhanced Mobilisation, homing and engraftment of Haematopoietic stem cells. European Haematology Review, 1(1), 47\u201349.","journal-title":"European Haematology Review"},{"issue":"11","key":"11047_CR51","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/ph15111391","volume":"15","author":"F Chen","year":"2022","unstructured":"Chen, F., et al. (2022). Human umbilical cord MSC delivered-soluble TRAIL inhibits the proliferation and promotes apoptosis of B-ALL cell in vitro and in vivo. Pharmaceuticals, 15(11), 1391.","journal-title":"Pharmaceuticals"},{"key":"11047_CR52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00277-020-04376-w","volume":"100","author":"L Wang","year":"2021","unstructured":"Wang, L., et al. (2021). Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: A meta-analysis. Annals of Hematology, 100, 563\u2013573.","journal-title":"Annals of Hematology"},{"key":"11047_CR53","doi-asserted-by":"crossref","unstructured":"Lu, W. (2020). AMD3100 attenuates post-traumatic osteoarthritis by maintaining transforming growth factor-\u03b21-induced expression of tissue inhibitor of metalloproteinase-3 via the phosphatidylinositol 3-kinase\/akt pathway. Frontiers in pharmacology, 10: p. 1554.","DOI":"10.3389\/fphar.2019.01554"},{"key":"11047_CR54","doi-asserted-by":"crossref","unstructured":"Li, N., et al. (2021). Atorvastatin Pre-treatment ameliorates mesenchymal stem cell migration through miR-146a\/CXCR4 signaling (Vol. 18, pp. 863\u2013873). Tissue Engineering & Regenerative Medicine.","DOI":"10.1007\/s13770-021-00362-z"},{"issue":"2","key":"11047_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4161\/cbt.22957","volume":"14","author":"C Ierano","year":"2012","unstructured":"Ierano, C., et al. (2012). Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration. Cancer Biology & Therapy, 14(2), 175\u2013183.","journal-title":"Cancer Biology & Therapy"},{"key":"11047_CR56","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/cts.13548","volume":"16","author":"AB Kagan","year":"2023","unstructured":"Kagan, A. B., et al. (2023). DNA methyltransferase inhibitor exposure\u2013response: Challenges and opportunities. Clinical & Translational Science, 16, 1309\u20131322.","journal-title":"Clinical & Translational Science"},{"key":"11047_CR57","doi-asserted-by":"publisher","first-page":"618378","DOI":"10.3389\/fgeed.2021.618378","volume":"3","author":"S Ferrari","year":"2021","unstructured":"Ferrari, S., et al. (2021). Gene editing of hematopoietic stem cells: Hopes and hurdles toward clinical translation. Frontiers in Genome Editing, 3, 618378.","journal-title":"Frontiers in Genome Editing"},{"issue":"3","key":"11047_CR58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano, S., et al. (2018). CRISPR-Mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circulation Research, 123(3), 335\u2013341.","journal-title":"Circulation Research"},{"issue":"3","key":"11047_CR59","doi-asserted-by":"publisher","first-page":"e10143","DOI":"10.1002\/btm2.10143","volume":"4","author":"AC Anselmo","year":"2019","unstructured":"Anselmo, A. C., & Mitragotri, S. (2019). Nanoparticles in the clinic: An update. Bioengineering & Translational Medicine, 4(3), e10143.","journal-title":"Bioengineering & Translational Medicine"},{"issue":"4","key":"11047_CR60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/13543776.2025.2462848","volume":"35","author":"Z Sahin","year":"2025","unstructured":"Sahin, Z., et al. (2025). Small molecule and peptide CXCR4 antagonists. A patent review from 2019 to 2024. Expert Opinion on Therapeutic Patents, 35(4), 357\u2013369.","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"12","key":"11047_CR61","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.bbmt.2020.08.013","volume":"26","author":"G. George","year":"2020","unstructured":"George, G. (2020). The effect of G-CSF use on hospital length of stay after an allogeneic hematopoietic cell transplantation: A retrospective multicenter cohort study. Biology of blood and marrow transplantation, 26(12), 2359.","journal-title":"Biology of blood and marrow transplantation"},{"key":"11047_CR62","doi-asserted-by":"crossref","unstructured":"Ratajczak, M. Z. (2020). Stem cells: Therapeutic applications (Vol. 1201). Springer Nature.","DOI":"10.1007\/978-3-030-31206-0"},{"key":"11047_CR63","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s12015-021-10272-1","volume":"17","author":"JB Menendez-Gonzalez","year":"2021","unstructured":"Menendez-Gonzalez, J. B., & Hoggatt, J. (2021). Hematopoietic stem cell mobilization: Current collection approaches, stem cell heterogeneity, and a proposed new method for stem cell transplant conditioning. Stem Cell Reviews and Reports, 17, 1939\u20131953.","journal-title":"Stem Cell Reviews and Reports"},{"key":"11047_CR64","doi-asserted-by":"publisher","first-page":"1081889","DOI":"10.3389\/fimmu.2022.1081889","volume":"13","author":"J Zhong","year":"2022","unstructured":"Zhong, J., et al. (2022). Single-cell RNA sequencing reveals the molecular features of peripheral blood immune cells in children, adults, and centenarians. Frontiers in Immunology, 13, 1081889.","journal-title":"Frontiers in Immunology"},{"key":"11047_CR65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12668-023-01250-7","volume":"14","author":"M Hariri","year":"2024","unstructured":"Hariri, M., et al. (2024). Biosensor-based nanodiagnosis of carcinoembryonic antigen (CEA): An approach to classification and precision detection of cancer biomarker. Bionanosci, 14, 429-446.","journal-title":"Bionanosci"},{"key":"11047_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11517-024-03199-5","volume":"63","author":"B Nejati","year":"2025","unstructured":"Nejati, B., et al. (2025). Cancer-on-chip: A breakthrough organ-on-a-chip technology in cancer cell modeling. Mol Biol Eng Comput, 63,321-337.","journal-title":"Mol Biol Eng Comput"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11047-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-11047-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11047-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:02:21Z","timestamp":1772625741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-11047-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["11047"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-11047-8","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"During the preparation of this work, the author(s) used ChatGPT to enhance the clarity, grammar, and flow of the writing. After using this tool\/service, the author(s) reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted Technologies in the Writing Process"}}]}}